PRE-FORUM
WORKSHOP
Date: Monday 1st March to Tuesday 2nd March 2010

Protocol Development and Implementation in ALL: Planning, Designing and Implementing A Leukemia Trial in Emerging Countries

“No child should die in the dawn of life.”

- Danny Thomas
Founder of St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Acute Lymphoblastic Leukemia

Minimal Residual Disease in Leukemia
CAMPANA, Dario, MD PhD
Professor and Vice Chair for Laboratory Research,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

The AIEOP-BFM Experience in Childhood ALL
CONTER, Valentino, MD
University of Milano-Bicocca, Ospedale S. Gerardo,
Department of Pediatrics,
Monza, ITALY

The Molecular Pathology of Acute Leukemia
DOWNING, James R., MD
Scientific Director,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

Target Identification and Targeted Therapy for ALL - Imatinib and Beyond
HUNGER, Stephen P, MD
Professor and Ergen Family Chair in Pediatric Cancer,
Chief, Section of Pediatric Hematology/Oncology/Bone Marrow, Transplantation and Director, Center for Cancer and Blood Disorders,
University of Colorado Denver School of Medicine,
The Children’s Hospital,
Aurora, Colorado, USA

Recent Advances in Childhood ALL
PUI, Ching-Hon MD
American Cancer Society Professor and Chair, Department of Oncology,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

Learning to Walk on Shifting Sands - Strategies to Improve the Outcome of Pediatric Acute Myeloid Leukemia
RIBEIRO, Raul MD
Professor and Director, Division of Leukemia/Lymphoma,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

Infectious Complications in Childhood Leukemia
SUNG, Lillian MD, PhD
Pediatric Hematology /Oncology
The Hospital for Sick Children
Toronto, Ontario, CANADA

BACK TO TOP

Non-Hodgkin’s Lymphoma – the BFM Experience
REITER, Alfred, MD
Children’s University Hospital and Justus-Liebig-University,
Department of Pediatric Hematology and Oncology,
Giessen, GERMANY

BACK TO TOP

Managing Common Side-Effects During ALL Therapy
HOWARD, Scott, MD, MS.
Director of Clinical Trials, International Outreach Program; Associate Professor, University of Tennessee College of Medicine,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

Compliance with Protocols in Childhood Leukemia
VEERMAN, Anjo, MD
Professor of Pediatrics, Vrije Universiteit,
Amsterdam, The NETHERLANDS

BACK TO TOP

Bone Marrow Transplantation in Childhood ALL
HANDGRETINGER, Rupert, MD
Professor and Chairman, Department of Hematology/Oncology and General Pediatrics Children’s University Hospital,
Tuebingen, GERMANY

Stem Cell Transplantation in Childhood Leukemias: St Jude Experience
LEUNG, Wing, MD PhD
Director, Division of Bone Marrow Transplant and Cellular Therapy,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

BACK TO TOP

Pediatric Brain Tumors – Successes and Challenges
GAJJAR, Amar, MD
Scott and Tracie Hamilton Endowed Chair,
Director, Division of Neuro Oncology,
Co Leader Neurobiology and Brain Tumor Program,
Co Chair and Member, Department of Oncology,
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

Multimodal Therapy for Childhood Bone and Soft Tissue Sarcomas
SPUNT, Sheri, MD
Associate Member
Division of Solid Tumors and Cancer Survivorship
St. Jude Children’s Research Hospital,
Memphis, Tennessee, USA

BACK TO TOP

ORGANIZERS